Proteomics International Laboratories ls launching its PromarkerEso esophageal cancer test globally, backed by a top-tier clinical board...

A Proteomics International Laboratories subsidiary has received an Australian patent for its finger-prick blood test that tracks muscle...

Assay plates on an automated platform using PromarkerD to test for the early signs of chronic kidney disease in type 2 diabetes patients....

Results from a trial of Proteomics International Laboratories’ PromarkerD blood test for the detection of chronic kidney disease have...

Proteomics International Laboratories has opened a new laboratory in the United States, certified by the State of California, to roll out...

OxiDx, a majority-owned subsidiary of biotech company Proteomics International, has revealed a simple fingerprick test to detect and...

Proteomics International’s game-changing PromarkerEndo diagnostic blood test for endometriosis has passed its latest clinical trials with...

Perth-based Proteomics International has received a $2.16m R&D for costs incurred in the previous financial year on the research of...

Proteomics International Laboratories (ASX: PIQ) has taken a significant new step in its fight against one of the world’s deadliest...

Proteomics International Laboratories (ASX: PIQ) has hired industry veteran Dr James Williams as a non-executive director in a boardroom...

Proteomics International Laboratories (ASX: PIQ) testing using its “PromarkerD” device that employs a simple blood test has shown a high...

Proteomics International Laboratories (ASX: PIQ) has sealed a new deal with medical diagnostics company Eurobio Scientific to distribute...

Proteomics International Laboratories (ASX: PIQ) is escalating its expansion into the European market after appointing Netherlands-based...

Research conducted by Proteomics International Laboratories (ASX: PIQ) and Curtin University has made a crucial discovery in...

ASX-listed Proteomics International (ASX: PIQ) has joined forces with England’s revered Oxford University as the medtech continues to...

Proteomics International Laboratories (ASX: PIQ) will continue important research and development for its diagnostic test products after...

Proteomics International Laboratories’ 66 per cent-owned subsidiary OxiDx has been awarded a European patent for its finger-prick...

Proteomics International Laboratories is showcasing its latest diagnostic milestones for endometriosis and oesophageal cancer in front of...

Proteomics International Laboratories has signed a licence agreement to sell its PromarkerD predictive test for diabetic kidney disease...

Proteomics International Laboratories is nudging closer to commercialising its PromarkerD predictive test for diabetic kidney disease...